The Amplify Weight Loss Drug & Treatment ETF (THNR) top stock holdings include Novo Nordisk A/S, Eli Lilly and Company, and Regeneron Pharmaceuticals. The top 22 THNR holdings ordered by weight make up 100.01% of the total fund. THNR is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete THNR stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.
Top 22 THNR Holdings
THNR Geographic Exposure
THNR's largest geographic exposure is United States at 133.6%, followed by Japan at 19.3%.
THNR Currency Exposure
THNR is predominantly exposed to USD at 153.9%, followed by HKD at 20.6%.
THNR Sector Exposure
THNR's largest sector exposure is Health Care at 184.9%.
THNR Industry Exposure
THNR's largest industry exposure is Biotechnology at 181.7%, followed by Pharmaceuticals at 3.2%.
THNR Sub-Industry Exposure
THNR's largest sub-industry exposure is Biotechnology at 181.7%, followed by Pharmaceuticals at 3.2%.
THNR Coupon Exposure
THNR's largest coupon exposure is 2-4 at 0.9%.
THNR Maturity Exposure
THNR's largest maturity exposure is 5-10 at 0.9%.
